The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation

(2015) Haowei Sun et al.   Clinical Lymphoma Myeloma & Leukemia

Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era

(2015) Chieh-Sheng Lu et al.   LEUKEMIA & LYMPHOMA

Serum albumin as a stable predictor of prognosis during initial treatment in patients with diffuse large B cell lymphoma

(2014) Jennifer Eatrides et al.   ANNALS OF HEMATOLOGY

The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China

(2014) Xiaoyang Li et al.   ANNALS OF HEMATOLOGY

A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2-microglobulin

(2014) Thomas Melchardt et al.   BRITISH JOURNAL OF HAEMATOLOGY

Double hit lymphoma: the MD Anderson Cancer Center clinical experience

(2014) Yasuhiro Oki et al.   BRITISH JOURNAL OF HAEMATOLOGY

The Modified Glasgow Prognostic Scores as a Predictor in Diffuse Large B Cell Lymphoma Treated with R-CHOP Regimen

(2014) Yundeok Kim et al.   YONSEI MEDICAL JOURNAL

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

(2013) Z. Zhou et al.   BLOOD

Double-hit Lymphomas Constitute a Highly Aggressive Subgroup in Diffuse Large B-cell Lymphomas in the Era of Rituximab

(2012) T. Kobayashi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

(2010) Paul N. Meyer et al.   JOURNAL OF CLINICAL ONCOLOGY

Systemic inflammation, nutritional status and survival in patients with cancer

(2009) Donald C McMillan   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE